Showing results (101-110 of 510) with videos related to

Sort By:
Pageof 51
Medical and Pediatric Oncology|January 1, 1982
Sex differences in prognosis of childhood T-cell leukemiaL Penchansky, T L Whiteside, M R Wollman, et al.
Hepatology (Baltimore, Md.)|August 1, 1989
Lymphokine-activated killer cell activity in patients with primary and metastatic malignant liver tumorsR E Schwarz, S Iwatsuki, R B Herberman, et al.
The Journal of Laboratory and Clinical Medicine|February 1, 1981
Abnormalities of T lymphocyte subsets in patients with progressive systemic sclerosis (PSS, scleroderma)T Inoshita, T L Whiteside, G P Rodnan, et al.
International Reviews of Immunology|March 7, 2002
Therapeutic activity of NK cells against tumorsP H Basse, T L Whiteside, W Chambers, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 1, 1987
Double immunoenzyme staining method for analysis of tissue and blood lymphocyte subsets with monoclonal antibodiesK Chen, A J Demetris, D H VanThiel, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1989
Unimpaired ability to generate adherent lymphokine-activated killer (A-LAK) cells in patients with primary or metastatic liver tumorsR E Schwarz, S Iwatsuki, R B Herberman, et al.
The Journal of Rheumatology|July 1, 1980
Crithidia luciliae assay for antibodies to native DNA in procainamide-induced lupus erythematosusJ A Dixon, L M Mulhern, T L Whiteside, et al.
Cellular Immunology|January 1, 1991
Adhesion characteristics of human interleukin 2-activated natural killer cellsR J Melder, E Walker, R B Herberman, et al.
Alcoholism, Clinical and Experimental Research|January 1, 1983
Lymphocyte subsets studied with monoclonal antibodies in liver tissues of patients with alcoholic liver diseaseL Si, T L Whiteside, R R Schade, et al.
Pageof 51